Learn about INVOKANA®, an SGLT2 inhibitor that helps lower blood sugar and risk of cardiovascular disease in adults. See full Prescribing & Safety Info. INVOKANA is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an INVOKANA mg once daily who have an eGFR of 60 mL/min/ m2. INVOKANA® is now the only oral diabetes treatment approved to in the INVOKANA® U.S. full Prescribing Information (PI).3 The PI also.

Author: Grozilkree Fegore
Country: Liberia
Language: English (Spanish)
Genre: Technology
Published (Last): 10 July 2011
Pages: 411
PDF File Size: 19.14 Mb
ePub File Size: 8.87 Mb
ISBN: 164-8-53991-880-2
Downloads: 86669
Price: Free* [*Free Regsitration Required]
Uploader: Zulkisho

The submission assumed that canagliflozin would predominantly substitute for the growing gliptin market. Promptly evaluate patients presenting with symptoms that may be associated with or suggestive of GI perforation.

Median time to complete resolution of neutropenia was 13 days range: Consider medication with antihistamines, acetaminophen, and corticosteroids.

Prompt hemodialysis is recommended to correct the acidosis and remove accumulated metformin. Effects on Serum Creatinine: Monitor patients for hypertension, hypokalemia, and fluid retention at least once a month.

Indication and Important Safety Information

Concurrent Active Severe Infections invo,ana Do not administer to patients with severe infections until the infection resolves. The PBAC agreed that the restriction proposed by the submission appropriately limits use to the third line setting in combination with metformin or a sulfonylurea in patients whose diabetes, as measured by HbA1c, is not controlled on treatment with metformin and a sulfonylurea.

Please refer to the full Prescribing Information or a complete list of adverse drug reactions. The submission assumed that the PBS listing of canagliflozin will not increase the current market. In studies, a roughly 2-fold increased risk of lower limb amputations was seen with canagliflozin. Targeted tuberculin testing and treatment of latent tuberculosis infection. Cardiomyopathy, including cardiac failure, congestive heart failure, ejection fraction ibvokana, diastolic dysfunction, or right ventricular dysfunction invokaa occur.


These rashes were mild to moderate in severity and did not limit therapy; there were no discontinuations due to rash.

In fact, studies have shown metformin plus canagliflozin led to a pound weight loss over one year in some patients, which is a big advantage in type 2 diabetes. Medically reviewed by L. Type 2 diabetes is a metabolic ivnokana characterised by hyperglycaemia resulting from resistance to the action of insulin, insufficient insulin secretion or both.

RxEconsult | Home

Accessed April 8, at https: PBAC agreed that uncertainty persisted regarding the cardiovascular safety profile of canagliflozin and invkoana that additional post-marketing studies commenced following the FDA recommendation of canagliflozin in March which include:. Increased dosages of corticosteroids may invo,ana used before, during, and after stressful situations. Cobicistat decreases estimated creatinine clearance CrCl due to inhibition of tubular secretion of creatinine without affecting actual renal glomerular function.

Hepatotoxicity, including hepatic failure, can occur.

TGA eBS – Product and Consumer Medicine Information

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Signs and symptoms may include respiratory symptoms, such as nasal congestion, cough, throat irritation, as well as chills, vomiting and nausea. But if it is almost time for next dose, skip the missed dose and take Invokana at your regularly scheduled time.

In turn, you eliminate more glucose in your urine which lowers your blood sugar levels. The PBAC recommended that cost-offsets be applied to canagliflozin to account for an increased rate of adverse events such as genital mycotic infections compared with sitagliptin. Nearly all reactions occurred during infusion or within 4 hours of completing an infusion.


Stop the infusion if the patient develops a mild to moderate infusion reaction. When compared to Januvia sitagliptin plus metformin, Invokana plus metformin has been shown to be better at lowering blood sugar and also leads to weight loss.

Canagliflozin, tablet, 100 mg and 300 mg, Invokana® – July 2013

A diagnosis of type 2 diabetes can be hard to swallow. Also, the FDA warned that patients taking canaglifozin should notify their doctor right away if they notice any new pain, tenderness, sores, ulcers, or infections in their legs or feet.

The third-party service providers, not Janssen, are responsible for the information and assistance provided under this program. If you notice signs of kidney injury, like decreased urine or swelling in the legs or feet, be sure to contact a healthcare provider immediately. However, the combination agents like Invokamet or Invokamet XR that contain metformin may be appropriate to start as a first-line agent in certain patients who need greater blood sugar control.

Evaluate renal function prior to initiation and periodically thereafter. UGT enzyme inducers speed up removal of Invokana from the body and make it less effective.

Falls were not associated with loss of consciousness or seizure. In patients with psoriatic arthritis, serious infections included cholecystitis.

Drug interactions should always be assessed whenever you start — or even stop — a medication. Evaluate patients for fracture and fall risk. The following was noted from the Phase III trials:. Subscribe to free Drugs. Invokana comes as a tablet taken once daily by invokaja.